Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
19.74
+1.17 (6.30%)
At close: Aug 19, 2026, 4:00 PM EDT
19.74
0.00 (0.00%)
After-hours: Aug 19, 2026, 4:10 PM EDT

Fulgent Genetics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
323.93322.67283.47289.21618.97992.58
Revenue Growth
6.83%13.83%-1.99%-53.27%-37.64%135.37%
Gross Profit
115.26130.88107.22104.46366.9777.05
Operating Income
-115.29-89.17-73.92-75.3181.5675.95
Net Income
-84.38-60.51-42.71-167.83143.4507.36
Earnings Per Share
-2.81-1.97-1.41-5.634.6316.38
EPS Growth
-----71.73%83.84%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Laboratory Services
323.37322.22283.47289.21618.97992.58
Therapeutic Development
-0.45----
Total
323.93322.67283.47289.21618.97992.58

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
551.35705.35828.46847.73852.88935.55
Total Debt
9.68.049.2316.5638.3330.2
Net Cash (Debt)
541.75697.31819.23831.17814.56905.35
Net Cash Growth
-29.60%-14.88%-1.44%2.04%-10.03%117.48%
Net Cash Per Share
17.9722.6627.1027.9126.3129.23

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-83.7-101.6421.0627253.52538.58
Capital Expenditures
-20.09-22.57-40.32-22.21-18.78-23.81
Free Cash Flow
-103.79-124.21-19.264.8234.75514.77
Free Cash Flow Growth
----97.96%-54.40%387.94%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
35.58%40.56%37.82%36.12%59.28%78.29%
Operating Margin
-35.59%-27.64%-26.08%-26.03%29.32%68.10%
Pretax Margin
-28.54%-21.70%-18.33%-60.19%29.73%68.61%
Profit Margin
-26.05%-18.75%-15.07%-58.03%23.17%51.12%
FCF Margin
-32.04%-38.50%-6.79%1.66%37.92%51.86%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
----6.285.91
Forward PE
-247.16247.16247.16247.1613.80
P/FCF Ratio
---178.633.835.83
PS Ratio
1.682.521.992.961.453.02